CompanyDeals

Bayer and Thermo Fisher Partner to Develop Rapid Companion Diagnostics for Precision Oncology

CompanyDrug

iRegene’s NouvSight001 Gains Orphan Drug Designation for Retinitis Pigmentosa Treatment

CompanyDrug

BMS Reports Positive Phase III Results for Opdivo and Yervoy in Advanced HCC

CompanyDeals

China Resources Guangdong Pharmaceutical Partners with BD to Enhance Drug and Device Distribution in GBA

DigitalR&D

CAIR Launches CARES Copilot 1.0: A Revolutionary AI Chatbot for Medical Diagnosis and Treatment

CompanyDeals

VIVA Biotech Secures Licensing Deal with Lonza for Advanced Bispecific Antibody Technology

CompanyDrug

Antengene’s ATG-022 Advances to Dose Expansion Phase in Phase II CLINCH Study for Solid Tumors

CompanyDrug

CSPC Pharmaceutical Secures NMPA Approval for Clinical Study of SYS6023 in Advanced Solid Tumors

Company

3SBio Reports 13.8% Revenue Growth in 2023, Driven by Strong Sales of Core Biologics

Company

Innovent Biologics Reports 36.2% Revenue Growth in 2023, Highlights Robust Product Sales

CompanyDrug

Jiangsu Hengrui Receives NMPA Approval for Phase Ib/II Study of HRS2398 in Advanced Solid Tumors

CompanyDeals

Zuellig Pharma Expands Commercialization Deal for Karo Healthcare’s Lamisil in Asian Markets